Bharat Biotech to start Phase-1 trials of COVID-19 intranasal vaccine in Feb-March
Posted by
www.biotecnika.org
Besides Covaxin, BharatBiotech has been actively working on developing
another vaccine, for which it tied up with Washington UniversitySchool
of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee
adenovirus), a single dose intranasal vaccine for COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-start-phase-1-trials-of-covid-19-intranasal-vaccine-in-feb-march/articleshow/80166140.cms
Subscribe to:
Post Comments (Atom)
Post a Comment